Uniplan Investment Counsel’s LeMaitre Vascular LMAT Stock Holding History

Uniplan Investment Counsel’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-451	Closed	-$49.3K	–	203
2026 Q1	$49.3K	Buy	+451	New	+$43K	0.01%	154
2020 Q4	–	Sell	-82,137	Closed	-$2.67M	–	127
2020 Q3	$2.67M	Buy	82,137 +588	+0.7%	+$17.7K	0.19%	82
2020 Q2	$2.15M	Buy	81,549 +340	+0.4%	+$8.89K	0.15%	88
2020 Q1	$2.02M	Buy	+81,209	New	+$2.51M	0.15%	80
2015 Q4	–	Sell	-345,934	Closed	-$4.22M	–	113
2015 Q3	$4.22M	Sell	345,934 -127,991	-27%	-$1.64M	0.2%	88
2015 Q2	$5.71M	Buy	+473,925	New	+$4.67M	0.26%	77

Other funds holding LMAT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.87B AUM 31.21% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Uniplan Investment Counsel's LMAT Position: Q2 2026 in Review

Uniplan Investment Counsel sold out of LeMaitre Vascular (LMAT) in Q2 2026, closing a stake of 451 shares — an estimated $49.3K sold.

Uniplan Investment Counsel first reported a position in LMAT in Q2 2015 and held it in 6 quarters. The position peaked at $5.71M in Q2 2015. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

Uniplan Investment Counsel reported no remaining LeMaitre Vascular position as of Q2 2026 after selling out during the quarter.
Uniplan Investment Counsel sold 451 LeMaitre Vascular shares in Q2 2026, an estimated $49.3K.
Uniplan Investment Counsel first reported a position in LeMaitre Vascular in Q2 2015 and held it in 6 quarters.
Uniplan Investment Counsel's LeMaitre Vascular position peaked at $5.71M in Q2 2015.
327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Uniplan Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.